Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Demyelinating disease and psoriasis: Interferon versus dimethyl fumarate.
Physiological Dynamics in Demyelinating Diseases: Unraveling Complex Relationships through Computer Modeling.
Optimizing the initial choice and timing of therapy in relapsing-remitting multiple sclerosis.
Estimating a Preference-Based Index for an Eight-Dimensional Health State Classification System for Multiple Sclerosis.
Lifestyle shapes the dialog between environment, microglia, and adult neurogenesis.
Circulating Follicular Regulatory T Cells Are Defective in Multiple Sclerosis.
A systematic review of stress-management interventions for multiple sclerosis patients.
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses.
In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106.
Dystonic pattern in a fibromyalgia patient: Relevance of a biopsychosocial rehabilitation approach.
Charles bonnet syndrome after herpes simplex encephalitis.
Novel composite MRI scale correlates highly with disability in multiple sclerosis patients.
EDSS Change Relates to Physical HRQoL While Relapse Occurrence Relates to Overall HRQoL in Patients with Multiple Sclerosis Receiving Subcutaneous Interferon β -1a.
Pharmacogenetics of multiple sclerosis: personalized therapy with immunomodulatory drugs.
[Coexistent depressive and anxiety disorders in epilepsy and multiple sclerosis: a challenge to neuropsychiatric practice.]
Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.
CTLA-4 +49 A/G and -318 C/T polymorphisms and susceptibility to multiple sclerosis: a meta-analysis.
Enhanced accumulation of Kir4.1 protein, but not mRNA, in a murine model of cuprizone-induced demyelination.
Functional connectivity changes within specific networks parallel the clinical evolution of multiple sclerosis.
Increased frequency and severity of restless legs syndrome in patients with neuromyelitis optica spectrum disorder.
Longitudinal extensive transverse myelitis with cervical epidural haematoma following dengue virus infection.
OCT and Visual Field Changes as Useful Markers for Follow-up of Axonal Loss in Multiple Sclerosis in Egyptian Patients.
Erratum to: 'Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial'.
Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method.
Functional involvement of γ-secretase in signaling of the triggering receptor expressed on myeloid cells-2 (TREM2).
Pages
« first
‹ previous
…
696
697
698
699
700
701
702
703
704
…
next ›
last »